The COX-2 selective blocker etodolac inhibits TNFα-induced apoptosis in isolated rabbit articular chondrocytes.

The COX-2 selective blocker etodolac inhibits TNFα-induced apoptosis in isolated rabbit articular chondrocytes.
复制标题

DOI:
10.3390/ijms141019705
复制
发表时间:
2013-09-30
影响因子:
5.6
通讯作者:
Matsusue Y
Matsusue Y
中科院分区:
生物学2区
文献类型:
--
作者:
Kumagai K;Kubo M;Imai S;Toyoda F;Maeda T;Okumura N;Matsuura H;Matsusue Y

文献摘要

参考文献

被引文献

相似文献

软骨细胞凋亡有助于骨关节炎(OA)软骨完整性的破坏。最近,我们报道了体积敏感Cl -电流(ICl,vol)的激活介导细胞收缩,引发兔关节软骨细胞凋亡。环氧合酶(COX)阻滞剂常用于OA的治疗。在本研究中,我们使用膜片钳技术检测了COX选择性阻滞剂对tnf α-诱导的兔软骨细胞ICl,vol活化的体外影响。将分离的软骨细胞暴露于TNFα后,膜Cl -电导明显增加。tnf α诱发的Cl -电流表现出与ICl相似的电生理和药理学特性。选择性COX-2阻滞剂依托度酸对细胞进行预处理可显著抑制ICl、TNFα对细胞体积的激活以及随后的凋亡事件,如凋亡细胞体积减少(AVD)和caspase-3/7活性升高。相比之下,COX-1阻滞剂对TNFα诱导的细胞体积减少或caspase-3/7活性增加没有影响。由此可见,cox -2选择性阻断剂对tnf α-诱导的凋亡事件具有抑制作用,提示该药物对OA具有治疗作用。
Chondrocyte apoptosis contributes to the disruption of cartilage integrity in osteoarthritis (OA). Recently, we reported that activation of volume-sensitive Cl− current (ICl,vol) mediates cell shrinkage, triggering apoptosis in rabbit articular chondrocytes. A cyclooxygenase (COX) blocker is frequently used for the treatment of OA. In the present study, we examined in vitro effects of selective blockers of COX on the TNFα-induced activation of ICl,vol in rabbit chondrocytes using the patch-clamp technique. Exposure of isolated chondrocytes to TNFα resulted in an obvious increase in membrane Cl− conductance. The TNFα-evoked Cl− current exhibited electrophysiological and pharmacological properties similar to those of ICl,vol. Pretreatment of cells with selective COX-2 blocker etodolac markedly inhibited ICl,vol activation by TNFα as well as subsequent apoptotic events such as apoptotic cell volume decrease (AVD) and elevation of caspase-3/7 activity. In contrast, a COX-1 blocker had no effect on the decrease in cell volume or the increase in caspase-3/7 activity induced by TNFα. Thus, the COX-2-selective blocker had an inhibitory effect on TNFα-induced apoptotic events, which suggests that this drug would have efficacy for the treatment of OA.
DOI: 10.1021/jm970036a
发表时间: 1997-05-23
影响因子: 7.3
作者:
Khanna, IK;Weier, RM;Isakson, PC
通讯作者: Isakson, PC
DOI: 10.1016/j.joca.2009.09.008
发表时间: 2010-03-01
影响因子: 7
作者:
Kim, J.;Xu, M.;Grishko, V.
通讯作者: Grishko, V.
DOI: 10.1085/jgp.101.6.801
发表时间: 1993-06-01
影响因子: 3.8
作者:
LEWIS, RS;ROSS, PE;CAHALAN, MD
通讯作者: CAHALAN, MD
DOI: 10.1113/jphysiol.1993.sp019807
发表时间: 1993-09-01
影响因子: 5.5
作者:
BENITAH, JP;GOMEZ, AM;LORENTE, P
通讯作者: LORENTE, P
DOI: 10.1016/j.joca.2006.01.005
发表时间: 2006-07-01
影响因子: 7
作者:
Lopez-Armada, M. J.;Carames, B.;Blanco, F. J.
通讯作者: Blanco, F. J.